AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
IMMUNOGLOBULINE HUMAINE POLYVALENTE
16 registrations across 1 African market— 0 active
Markets with IMMUNOGLOBULINE HUMAINE POLYVALENTE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| INTRATECT Solution injectable pour perfusion / 10gr/100ml | 🇹🇳Tunisia | BIOTEST PHARMA GmbH | expired | Apr 2017 |
| INTRATECT Solution injectable pour perfusion / 5gr/50ml | 🇹🇳Tunisia | BIOTEST PHARMA GmbH | expired | Apr 2017 |
| INTRATECT Solution injectable pour perfusion / 10 gr/200ml | 🇹🇳Tunisia | BIOTEST PHARMA GmbH | expired | Apr 2017 |
| OCTAGAM Solution injectable pour perfusion / 5 GR/100 ML | 🇹🇳Tunisia | OCTAPHARMA pharmazeutika produktionges.m.b.h | expired | Aug 2013 |
| IG VENA Solution injectable pour perfusion / 5 g/100 ml | 🇹🇳Tunisia | KEDRION S.p.A | expired | Aug 2013 |
| OCTAGAM Solution injectable pour perfusion / 2.5 gr | 🇹🇳Tunisia | OCTAPHARMA pharmazeutika produktionges.m.b.h | expired | Aug 2013 |
| IG VENA Solution injectable pour perfusion / 2.5g/50 ml | 🇹🇳Tunisia | KEDRION S.p.A | expired | Aug 2013 |
| PRIVIGEN (10 GR) Solution injectable pour perfusion / 10% | 🇹🇳Tunisia | CSL Behring AG | expired | Jul 2012 |
| PRIVIGEN (2.5GR) Solution injectable pour perfusion / 10% | 🇹🇳Tunisia | CSL Behring AG | expired | Jul 2012 |
| PRIVIGEN (5 GR) Solution injectable pour perfusion / 10% | 🇹🇳Tunisia | CSL Behring AG | expired | Jul 2012 |
| INTRATECT Solution injectable pour perfusion / 5 gr/100ml | 🇹🇳Tunisia | BIOTEST PHARMA GmbH | expired | Aug 2007 |
| INTRATECT Solution injectable pour perfusion / 2.5 gr/50ml | 🇹🇳Tunisia | BIOTEST PHARMA GmbH | expired | Aug 2007 |
| TEGELINE Pdre p.prep.injectable / 50 mg/ml | 🇹🇳Tunisia | LFB-Biomédicaments | expired | May 1998 |
| TEGELINE Pdre p.prep.injectable / 50 mg/ml | 🇹🇳Tunisia | LFB-Biomédicaments | expired | May 1998 |
| TEGELINE Pdre p.prep.injectable / 50 mg/ml | 🇹🇳Tunisia | LFB-Biomédicaments | expired | May 1998 |
| TEGELINE PERFUSION Pdre p.prep.injectable / 50 mg/ml | 🇹🇳Tunisia | LFB-Biomédicaments | expired | May 1998 |
IMMUNOGLOBULINE HUMAINE POLYVALENTE in Africa — Regulatory Overview
IMMUNOGLOBULINE HUMAINE POLYVALENTE is registered across 1 African markets with 16 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 16 registrations, 0 (0%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.